Search Results - "Rinder, Henry M"

Refine Results
  1. 1

    Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure‐Related Bleeding in Decompensated Cirrhosis by Zanetto, Alberto, Rinder, Henry M., Senzolo, Marco, Simioni, Paolo, Garcia‐Tsao, Guadalupe

    Published in Hepatology communications (01-02-2021)
    “…In patients with decompensated cirrhosis, procedure‐related bleeding is a potentially lethal complication. Routine coagulation tests such as international…”
    Get full text
    Journal Article
  2. 2

    Neutrophil CD64 as a Diagnostic Marker in Neonatal Sepsis by Streimish, Iris, Bizzarro, Matthew, Northrup, Veronika, Wang, Chao, Renna, Sara, Koval, Nancy, Li, Fang-Yong, Ehrenkranz, Richard, Rinder, Henry M, Bhandari, Vineet

    Published in The Pediatric infectious disease journal (01-07-2012)
    “…We assessed neutrophil CD64 as a diagnostic marker for neonatal sepsis. For early-onset sepsis, the CD64 index with a cut-point value of 2.38 had sensitivity,…”
    Get full text
    Journal Article
  3. 3

    Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice by Angelopoulou, Maria, Novelli, Enrico, Grove, Joanna E, Rinder, Henry M, Civin, Curt, Cheng, Linzhao, Krause, Diane S

    Published in Experimental hematology (01-05-2003)
    “…Objective. For approximately 5% of autologous transplant recipients and a higher proportion of allogeneic transplant recipients, low level and delayed platelet…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: Results of a double-blind, placebo-controlled, randomized trial by Tang, Yi-Da, MD, PhD, Hasan, Faisal, MD, PhD, Giordano, Frank J., MD, Pfau, Stephen, MD, Rinder, Henry M., MD, Katz, Stuart D., MD

    Published in The American heart journal (01-12-2009)
    “…Background Erythropoietin mitigates myocardial damage and improves ventricular performance after experimental ischemic injury. This study assessed safety and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different Anticoagulants by Khan, Waleed, Tormey, Christopher A, Rinder, Henry M, Siddon, Alexa J

    Published in American journal of clinical pathology (02-05-2023)
    “…Abstract Objectives Clinical experts recommend against testing for lupus anticoagulant (LAC) during anticoagulation. Methods We quantitated the risk of a…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies by Gu, Sean X., Butt, Ayesha, Schulz, Vincent P., Rinder, Henry M., Lee, Alfred I., Gallagher, Patrick G., Hwa, John, Bona, Robert D.

    Published in Blood cells, molecules, & diseases (01-02-2025)
    “…Inherited platelet disorders (IPDs) are a heterogeneous group of conditions that present significant challenges in diagnosis and management. Here, we report…”
    Get full text
    Journal Article
  14. 14

    Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient by Jacobs, Jeremy W., Gisriel, Savanah D., Iyer, Krishna, Rinder, Henry M.

    Published in Journal of thrombosis and thrombolysis (01-05-2022)
    “…Acquired hemophilia A, caused by autoantibodies that bind to and neutralize the activity of coagulation factor VIII (FVIII), almost universally presents as a…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Overall survival in TP53-mutated AML and MDS by Puzo, Christian J, Hager, Karl M, Rinder, Henry M, Weinberg, Olga K, Siddon, Alexa J

    Published in Annals of hematology (24-10-2024)
    “…TP53 mutations in patients with AML and MDS frequently portend a poor prognosis, related to both p53 allele status and blast count. In 2022, the ICC and WHO…”
    Get full text
    Journal Article
  17. 17

    Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: Results of a double-blind, placebo-controlled randomized trial by Tang, Yi-Da, MD, PhD, Rinder, Henry M., MD, Katz, Stuart D., MD

    Published in The American heart journal (01-09-2007)
    “…Background Recombinant human erythropoietin (rHuEpo) reduces myocardial injury in experimental ischemia and has been proposed as a cardioprotective agent for…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Botulism mimicking Guillain‐Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis by Silva Campos, Juan J., Abels, Elizabeth, Rinder, Henry M., Tormey, Christopher A., Jacobs, Jeremy W.

    Published in Journal of clinical apheresis (01-12-2023)
    “…Guillain‐Barré syndrome (GBS) is an immune‐mediated polyradiculoneuropathy and the most common cause of acute flaccid paralysis worldwide. GBS classically…”
    Get full text
    Journal Article
  20. 20

    Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review by Jacobs, Jeremy W, Sharma, Deva, Stephens, Laura D, Figueroa Villalba, Cristina A, Rinder, Henry M, Woo, Jennifer S, Wheeler, Allison P, Gerberi, Dana, Goel, Ruchika, Tormey, Christopher A, Booth, Garrett S, Bloch, Evan M, Adkins, Brian D

    Published in British journal of haematology (01-04-2024)
    “…The thrombotic risk with haemoglobin C trait (HbAC) or haemoglobin C disease (HbCC) is unclear. However, individuals with HbCC have demonstrated chronic…”
    Get full text
    Journal Article